[ad_1]
LONDON (Reuters) – Scientists at Kings College London have come up with a revolutionary new treatment that could change the rules of the game for thousands of men with advanced prostate cancer.
According to NewsMax, the new treatment contains an industrial protein called interleukin or IL
15, is injected into the tumor, which increases the number of immune cells that fight cancer, destroy malignant cells and reduce tumors.
Through clinical trials, scientists hope that the protein will not only reduce tumors, but will also provide permanent protection against the disease so that it does not return.
According to a previous report from the British Daily Mail, human cells naturally contain IL protein
15, while reinjection of protein helps to increase levels, which supports the immune system in its fight against cancer cells.
Prostate cancer causes the death of three quarters of men infected at an advanced stage, within 4 years of infection.
The researchers hope the new technology will help prevent the spread of cancer to other organs and prevent medical complications.
According to senior researcher at King's College, Christine Gallustian, early laboratory experiments have shown that IL-15 is able to reduce tumors by more than half.
[ad_2]
Source link
